CD4 and glioblastoma: Tregs have been identified as a pro-tumor subpopulation of CD4+ T cells in GBM tumor tissues and the circulatory system, which can direct cytotoxic T lymphocytes (CTLs) by suppressing tumor cell immune responses (59).